BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 3034933)

  • 21. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein.
    Dang CV; McGuire M; Buckmire M; Lee WM
    Nature; 1989 Feb; 337(6208):664-6. PubMed ID: 2645525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype.
    Xu L; Meng Y; Wallen R; DePinho RA
    Oncogene; 1995 Nov; 11(9):1865-72. PubMed ID: 7478616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of first exon/intron sequences in the regulation of myc family oncogenic potency.
    Xu L; Wallen R; Patel V; DePinho RA
    Oncogene; 1993 Sep; 8(9):2547-53. PubMed ID: 8361763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1.
    van Dam H; Offringa R; Smits AM; Bos JL; Jones NC; van der Eb AJ
    Oncogene; 1989 Oct; 4(10):1207-12. PubMed ID: 2529466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fused transcripts of c-myc and a new cellular locus, hcr in a primary liver tumor.
    Etiemble J; Möröy T; Jacquemin E; Tiollais P; Buendia MA
    Oncogene; 1989 Jan; 4(1):51-7. PubMed ID: 2644611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain.
    Fujiwara KT; Kataoka K; Nishizawa M
    Oncogene; 1993 Sep; 8(9):2371-80. PubMed ID: 8361754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive relaxation of Go-arrest controls and altered responsiveness to insulin, EGF and thrombin in CCL39 lung fibroblasts over-expressing myc and ras oncogenes.
    Pichon F; Seuwen K; Pouysségur J; Lagarde AE
    Oncogene; 1988 Oct; 3(4):373-81. PubMed ID: 3078948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogenes and their mechanisms of action.
    Găldean D
    Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
    [No Abstract]   [Full Text] [Related]  

  • 34. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
    Taparowsky EJ; Heaney ML; Parsons JT
    Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal location of N-myc and L-myc genes in the mouse.
    Campbell GR; Zimmerman K; Blank RD; Alt FW; D'Eustachio P
    Oncogene Res; 1989; 4(1):47-54. PubMed ID: 2654812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transforming activity of the chicken c-myc gene can be potentiated by mutations.
    Frykberg L; Graf T; Vennström B
    Oncogene; 1987; 1(4):415-22. PubMed ID: 3330784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine.
    Hsieh LL; Hsiao WL; Peraino C; Maronpot RR; Weinstein IB
    Cancer Res; 1987 Jul; 47(13):3421-4. PubMed ID: 3555772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human myc gene family: structure and activity of L-myc and an L-myc pseudogene.
    DePinho RA; Hatton KS; Tesfaye A; Yancopoulos GD; Alt FW
    Genes Dev; 1987 Dec; 1(10):1311-26. PubMed ID: 3322939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.